Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0019829 (Hodgkin's disease)
 30,247 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Serum immunoglobulin levels were measured in 105 patients with untreated Hodgkin's disease (HD) and 80 with non-HD lymphomas. Significant increases in IgG and IgE occurred in the whole HD group. When compared with the histological types of HD, increases of IgG, IgA AND IgE were seen in nodular sclerosis and of IgE alone in mixed-cellularity and lymphocyte-predominant types. In relation to the stage of disease spread, increases of IgG, IgA AND IgE occurred in Stages II and III, while in Stage IV, although IgE was raised, IgM in males and IgD fell significantly. Paired serum samples taken 10-14 months apart showed falls of IgM and IgD after radiotherapy, and of all Ig classes except IgD after chemotherapy. Decreased levels of IgM in females, IgG and IgA were found in the non-HD lymphomas. When analysed in terms of lymphnode histology, decreased IgG, IgA, IgM and IgE occurred in well differentiated lymphocytic lymphomas, decreased IgA alone in poorly differentiated lymphocytic lymphomas and decreased IgD in nodular types of lymphoma.
 ...
PMID:Serum immunoglobulins G, A, M, D and E concentrations in lymphomas. 50 66

Serum immunoglobulin concentrations have been measured in 31 patients with Hodgkin's lymphoma and related to disease activity and clinical stage. The patients with active untreated disease, the mean IgA concentration was significantly above the normal mean level and the mean IgM concentration was normal. No significant correlation was found between high IgA concentrations and liver involvement. There were decreased mean IgA and IgM concentrations during remission. The changes in immunoglobulin concentrations were found to be dependent on the clinical stage. The data suggest that in certain patients with active Hodgkin's lymphoma, the humoral-mediated immunity may be affected in addition to the cellular-mediated immunity.
 ...
PMID:The prognostic value of serum innumoglobulin levels in Hodgkin's disease. 53 Mar 36

In the present study, 15 children with non-Hodgkin lymphoma have been immunologically evaluated by the following parameters on peripheral blood (PB) lymphocytes: phytohemagglutinin responsiveness (PHA-r); non-immune rosette formation with sheep red blood cells (RF-L) as T-cell marker; presence of surface immunoglobulins (sIg-L) as B-cell marker; serum immunoglobulins levels (IgA, IgM, IgG). Our patients (pts) have been divided in two groups: the first one includes 10 children without PB involvement; the second one includes 5 pts with bone-marrow and PB invasion. From our data it appears that: 1) the majority of pts of the first group presented normal values of membrane markers; PHA-r was impaired in 4/8 pts; 2) in pts with PB invasion absolute number of B and "null" cells was always abnormal and PHA-r altered; 3) in the second group of pts, a "null" cell origin can be suggested by the high percentage and absolute number of cells without surface markers. In our opinion, the high incidence of "null" cells represents the most relevant question: whether they are cells deprived of specific markers, or endowed with markers not identifiable by our current techniques, remains to be established.
 ...
PMID:Immunological evaluation of 15 children with non-Hodgkin lymphoma. 58 Feb 50

The authors examined a course of immunoglobulin values (IgA, IgG, IgM) in 40 patients with the Hodgkin's disease and repeatedly in 11 healthy persons. In the patients they followed the levels of the immunoglobulins during the disease, up to 5 years. In untreated patients there were statistically significant increased IgA levels and insignificant increase of IgG. In the course of remission the immunoglobulin values were normalized. The radiotherapy did not affect significantly the value of immunoglobulins, the combined chemotherapy (COPP) led to a drop of this level. The levels of immunoglobulins are recovered after chemotherapy in the case of successful treatment. In terms of the prognosis the authors consider as unfavorable high increase in the immunoglobulin levels in untreated patients and their rapid drop during the chemotherapy. They observed an average preterminal drop of the IgA by 27%, IgG by 23% and IgM by 44% with respect to controls.
 ...
PMID:Immunoglobin levels in patients with Hodgkin's disease. 75 17

An immunoglobulin-enzyme bridge technique has been employed for the selective localization of immunoglobulin-producing cells in spleen, lymph nodes, and lymphoreticular tumors fixed highly for optimal immunocytochemistry or processed routinely for surgical diagnosis. Immunostaining for immunoglobulin was encountered consistently in the specially fixed tissues and was observed in some of the surgical specimens in areas where presumably fixation was satisfactory. Many, but not all, of the tumor cells in histocytic lymphoma (reticulum cell sarcoma) of spleen and of brain stained for IgG, but none evidenced reactivity for IgM or IgA. In Hodgkin's tumors, the prevalence of IgG-reactive stromal immunocytes in or between tumor areas was greatest in the nodular sclerosing form of the disease, abundant in mixed cellular, and least in lymphocyte-predominant and lymphocyte-depleted types. Immunocytes showing reactivity for IgG greatly exceeded those staining for IgM or IgA. Hodgkin's tumor cells immunostained frequently for IgG, infrequently for IgM, not at all for IgA, and in one instance, stained for k but not for lambda light chains. Individual tumor cells failed to stain for more than one type of Ig or light chain. The proportion of Ig reactive vs. unstained tumor cells correlated with the prevalence of immunocytes in the different Hodgkin's categories. Reed-Sternberg cells differed in their fine structure in ways which possibly correspond with the presence or absence of Ig shown at the light microscope level. Tumor cells in Hodgkin's disease and reticulum cell sarcoma also disclosed argyrophilia and strong staining indicative of ribonucleic acid with a Schiff-methylene blue procedure.
 ...
PMID:The cytochemical demonstration of intracellular immunoglobulin. In neoplasms of lymphoreticular tissue. 76 63

IgG, IgA and IgM were determined in 68, and IgE in 30 patients with Hodgkin's disease. Their relation to the dissemination stage, histological type, clinical stage and peripheral lymphocytes as well as the correlation of IgE to the peripheral eosinophils was investigated. In the untreated collective all Ig concentrations were above normal, but in the treated patients only IgG and IgE. With increasing dissemination, there was a decline of IgG, IgA and IgM in both groups which, however, was only significant for IgM. IgM was lowered in the lymphocytopenic type, raised in nodular sclerosis. There is a confirmed correlation between the absolute peripheral lymphocytes and IgM and between the peripheral eosinophils and IgE. IgE and IgA are slightly and IgM significantly lowered in the treated compared with the untreated patients. The findings suggest a disturbance of the humoral immunity in stage IV, in the lymphocytopenic type and in the treated patients.
 ...
PMID:[Immunglobulins G, A, M, and E in lymphogranulomatosis (author's transl)]. 81 17

Sixty-two of 1242 patients with M components were found to have lymphoma. There were 33 patients with immunoglobulin M(IgM), 20 WITH IgG, 5 with IgA, and one patient with Bence Jones protein M components. Three patients had biclonal gammopathy. The types of lymphoma were: lymphocytic, 31; histiocytic, 12; mixed cell, 4; stem cell, 2; Burkitt's, 1; Hodgkin's disease, 9; and unclassified, 3. All patients were in stages III or IV of lymphoma, and the average duration of disease was 29.3 months when M components were detected. Anemia, abnormal peripheral blood lymphocytes, and lymphomatous involvement of the bone marrow were especially common among patients with IgM M components. Osteolytic lesions were found in 12 patients and osteosclerotic lesions in one. A second malignancy occurred in eight patients. The level of M component was below 1.0 gm/dl in 55 per cent of patients. Significant suppression of normal immunoglobulin levels in the serum was noted in 4 and 16 patients with IgG and IgM components, respectively. Bence Jones proteinuria was found in 19 per cent, cryoglobulinemia in 11 per cent, and cold agglutinins, all of anti-i specificity, in 10 per cent of the patients. Most of the M components decreased during therapy. Only two M components gradually increased. The mean survival of 39 patients who died was 10.4 months. The living patients have been followed for a mean period of 21.2 months. The presence of M components in lymphoma may suggest B cell origin of the tumor but the coexistence of plasma cell dyscrasia cannot be ruled out.
 ...
PMID:M components associated with lymphoma: a review of 62 cases. 82 10

Sixty-two patients with Hodgkin's disease have been followed for one year from the start of treatment. Immunological assessments were repeated after intensive treatment, in patients relapsing and in those in remission at one year. In patients achieving remission, overall cellular immunity, after deteriorating with therapy, particularly cytotoxic chemotherapy, returned to pre-treatment levels in remission when there was little evidence of cellular immune disturbance. Serum IgG and IgM levels fell with intensive chemotherapy in splenectomized patients. IgA and IgM levels were lower (irrespective of splenectomy or therapy status) in remission than at presentation or after treatment. Relapse or non-response was usually associated with deteriorating cellular immunity. Herpes zoster/varicella and candida infections (seen in 6 patients) were preceded by, or associated with, deterioration of cellular immunity.
 ...
PMID:Follow-up studies on the immune status of patients with Hodgkin's disease after splenectomy and treatment, in relapse and remission. 92 91

Tonsils are lymphatic organs carrying out functions of humoral and cellular immunity. They form a local immunologic barrier; they are also involved in general immunologic defence mechanisms. Tonsillectomy or the destruction of tonsils by infections does not reduce the immunoglobulin concentration and antibody titres in peripheral blood. Only the local formation of IgA antibodies against poliomyelitis antigen seems to be impaired at least for a short time. The clinical relevance of this finding is unknown. Signs of defects in immunosurveillance, which were found in some study groups resulting from an increase of the morbidity rates of Hodgkin's disease and thyroid carcinoma, must be considered seriously although there is no statistic evidence for an increase of tumor frequency after tonsillectomy. The indication for tonsillectomy must be decided on clinical findings. Signs for a reduction of local antibody synthesis or for a possible diminuation of immunosurveillance should serve to critical indication.
 ...
PMID:[Tonsils and immunology (author's transl)]. 110 43

The immune status of 17 patients with Hodgkin's disease was studied before and after splenectomy (undertaken in staging laparotomy) and during chemotherapy or after radiotherapy. The findings were compared with those in 19 patients not selected for splenectomy. Serum IgA and IgM levels became significantly lower after treatment in the splenectomy group. Cell-mediated immunity was depressed mainly in patients receiving quadruple cytotoxic chemotherapy. Neutrophil function was normal or enhanced and was unchanged after splenectomy and treatment despite changes in neutrophil counts. Three patients who underwent splenectomy suffered fatal septicaemia. These results suggest that humoral immunity is depressed by treatment in patients who have undergon splenectomy, and the benefits of early accurate staging must be weighed against the likelihood of infective complications.
 ...
PMID:Changes in immune status in patients undergoing splenectomy for the staging of Hodgkin's disease. 124 37


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>